Home › Ulcerative Colitis › Minnesota › Rochester
Ulcerative Colitis clinical trials in Rochester, MN
5 studies for Ulcerative Colitis are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RecruitingPhase 2
- Site 028, Rochester
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
RecruitingPhase 2/3
- Mayo Clinic in Rochester, Minnesota, Rochester
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Mayo Clinic in Rochester, Minnesota, Rochester
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
RecruitingPhase 1
- Mayo Clinic, Rochester
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
Recruiting
- Mayo Clinic, Rochester
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- New York City, NY24 studies
- Orlando, FL23 studies
- Miami, FL22 studies
- Houston, TX18 studies
- San Antonio, TX16 studies
- San Diego, CA16 studies
- Tacoma, WA15 studies
- Chicago, IL15 studies
- St. Louis, MO14 studies
- Tyler, TX14 studies
- Colorado Springs, CO14 studies
- Los Angeles, CA13 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer38 studies
- Cancer (all types)31 studies
- Metastatic Cancer30 studies
- Colorectal Cancer29 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer23 studies
- Multiple Myeloma23 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Lung Cancer20 studies
- Chronic Lymphocytic Leukemia19 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.